A.I. Learns to Write in DNA
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
TechCrunch reports that Microsoft disclosed the financial performance of both its AI investments in fiscal Q4 earnings — and the results are lopsided. The company logged $3.2 billion in gains from its Anthropic stake during the quarter, while returns from its OpenAI investment were characterized only as "mixed."
It's the first time Microsoft has publicly broken out how these two rival bets are performing, and the language tells a story. "Mixed" is a conspicuously vague term for an investment that sits at the center of Microsoft's AI strategy — one the source describes as "what was supposed to be Redmond's crown jewel partnership."
The disclosure doesn't detail what "mixed" means in dollar terms for the OpenAI stake. What it does make clear is that Anthropic — maker of Claude — is producing the better-documented returns of the two. The contrast raises questions the source leaves open: whether the terms of the OpenAI arrangement have delivered the value originally expected.
For an industry that rarely puts specific dollar figures on AI investment returns, Microsoft's willingness to break these two bets apart is notable. The numbers now available favor Anthropic — and the word "mixed" is doing a lot of work on the other side of the ledger.
All comments are reviewed before appearing. Keep it respectful.
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
The Trump administration has no idea on how to handle open-source and open-weight AI models from China.
Google is consolidating AI leadership in California but the reorganization is pushing out the engineers who built its AI division